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By preventing the binding of this internal ligand, the Ridgefield, Connecticut 06877
molecules prevent the stabilization of the high-affinity
Selected Readingstate of the I-domain and thus allosterically prevent li-
gand binding.
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regulate the intensity, duration, and quality of responsesDefining Control: Regulation of
to cytokines. SOCS protein expression is induced byDendritic Cell Activation and cytokines, and once expressed SOCS proteins function
as components of a negative feedback loop to inhibitImmune Homeostasis by SOCS1
the cytokine signaling pathway. A prototypic member
of this family, SOCS1, appears to play a pivotal role in
the regulation of immune homeostasis. SOCS1-deficient
SOCS1 is a key regulator of cytokine signaling and mice die neonatally from the toxic effects of uncontrolled
is important for maintaining balance in the immune interferon- (IFN) signaling, implicating SOCS1 as a
system. In addition to roles in T, NKT, and macrophage critical regulator of this inflammatory cytokine (Alexan-
cell function, a new study indicates that SOCS1 modu- der et al., 1999).
lates dendritic cell activation and may help prevent Given the neonatal mortality and complex inflamma-
autoimmunity. tory pathology of SOCS1/ mice, many groups have
adopted strategies whereby SOCS1 deficiency is gener-
The response to infection and maintenance of immune ated in the context of a healthy adult mouse, in order
homeostasis requires precise coordination of many cell to define the role of SOCS1 in different cell lineages.
types. Communication between cells is key to sustaining Studies of mice lacking both SOCS1 and IFN, which are
a balanced immune system. Some of the important me- healthy and survive to adulthood, have shown SOCS1 to
diators of communication between cells are secreted be crucial for the maintenance of T cell homeostasis
proteins known as cytokines. Once produced, cytokines (Cornish et al., 2003). Specific deletion of SOCS1 from
bind to specific receptors on the surface of target cells T and NKT cells alone, however, is insufficient to induce
and activate many intracellular signaling pathways, the inflammation characteristic of SOCS1/ mice, indi-
among which the best defined is the janus kinase (JAK)/ cating that the absence of SOCS1 in other tissues also
signal transducer and activator of transcription (STAT) contributes to this disease (Chong et al., 2003). A role
pathway. Activated STATs dimerize and accumulate in for SOCS1 in innate immunity has been shown by injec-
the nucleus where they increase the transcription of tion of SOCS1/ IFN/ mice with LPS. SOCS1-defi-
genes required for induction of the appropriate biologi- cient mice were highly sensitive to LPS-induced lethal-
cal response. Responses to these potent molecules are ity, and LPS-induced macrophage activation was
typically transient and in the absence of appropriate similarly perturbed (Kinjyo et al., 2002).
regulation lead to imbalance in the immune system, re- In this issue of Immunity, a paper by Hanada et al.
sulting on one hand in immunodeficiency and on the describes a novel twist on this approach. This group
other in autoimmunity and inflammation. generated SOCS1-deficient mice in which SOCS1 ex-
pression was restored specifically in T and B lympho-The suppressor of cytokine signaling (SOCS) proteins
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cytes (SOCS1/Tg). A major caveat with this story is tumor necrosis factor ligand superfamily, are known to
be inducible by cytokine, and can induce maturationthat the restoration of expression is by no means physio-
logical. Unlike the normal situation, in which SOCS ex- and immunoglobulin production by B cells (Litinskiy et
al., 2002). It is probable, therefore, that abnormal activa-pression is induced following the initiation of cytokine
signaling, the transgenic expression of SOCS1 in this tion of DC in response to cytokine leads to increased
production of these B cell factors that in turn inducestudy occurs prior to cytokine stimulation. These mice
were viable and lacked the liver pathology that typifies abnormal B cell behavior and contribute to the autoim-
mune phenotype. The extent to which the absence ofSOCS1-deficient mice but developed systemic autoim-
munity as young adults. A previous report detailed T cell SOCS1 in DC, the absence of SOCS1 in other nonhema-
anomalies in SOCS1 transgenic mice in which SOCS1 topoietic cells, and the transgenic expression of SOCS1
was expressed in T and NKT cells (Fujimoto et al., 2000); in T and B cells combine to generate the autoimmune
however, there were no apparent defects in T or B cell disease remains open. Maybe the only way to tease the
differentiation or function in SOCS1/Tg mice pro- alternatives apart is to delete SOCS1 specifically in DC
duced in this study. Whether the lymphoid compart- cells using Cre-loxP technology.
ments of these animals are entirely normal will require Considering that SOCS1 appears essential for main-
a more in depth analysis. taining immune homeostasis in mice, perhaps the most
The autoimmune phenotype that develops in important question for future studies is whether changes
SOCS1/Tg mice is reminiscent of systemic lupus ery- in SOCS1 activity contribute in any way to human auto-
thematosus and includes autoantibody production, skin immunity.
lesions, and hypergammaglobulinemia. Although in-
flammatory lesions develop in SOCS1/ IFN/mice,
Robyn Starr and Douglas J. Hiltonthese are qualitatively different in nature and tend to
The Walter and Eliza Hall Institute of Medicaloccur in older mice (Metcalf et al., 2002). This suggests
Research andthat the autoimmune phenotype of SOCS1/Tg mice is
The Cooperative Research Centre for Cellularat least partly dependent on IFN.
Growth FactorsThe production of autoantibodies and hypergamma-
Melbourne, Australiaglobulinemia was somewhat surprising, given that B
cells in these mice express SOCS1 and were shown to
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tures, whereas there was no evidence for abnormal acti-
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ation of B cells relative to controls. 583–591.
How do DC induce abnormal B cell behavior? Hanada Litinskiy, M.B., Nardelli, B., Hilbert, D.M., He, B., Schaffer, A., Casali,
et al. show that the expression of two B cell growth and P., and Cerutti, A. (2002). Nat. Immunol. 3, 822–829.
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